Back to mobile site
Get it on Google Play

FDA approves second OTC naloxone nasal spray, Rextovy

June 16, 2026 10:08 AM EDT Send to a Friend
The U.S. Food and Drug Administration has approved Rextovy, a 4 milligram naloxone hydrochloride nasal spray, for over-the-counter sale as ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login